sabarubicin has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belevich, YV; Dygai, AM; Goldberg, AV; Goldberg, VE; Miroshnichenko, LA; Polyakova, TY; Popova, NO; Simanina, EV; Simolina, EI; Tuzikova, TP; Udut, EV; Vysotskaya, VV; Zhdanov, VV; Zyuz'kov, GN | 1 |
| Benzo, A; Bigioni, M; Binaschi, M; Caroli, S; Crea, A; Cubadda, F; Curatella, B; Irrissuto, C; Lopez, G; Maggi, CA; Manzini, S | 1 |
2 other study(ies) available for sabarubicin and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Assessment of Erythroid and Granulocytic Hematopoietic Lineages in Patients with Non-Small-Cell Lung Carcinoma.
Topics: Anthracyclines; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Differentiation; Cisplatin; Disaccharides; Docetaxel; Doxorubicin; Erythropoiesis; Granulocytes; Hematopoietic Stem Cells; Humans; Lung Neoplasms; Macrolides; Nitrosourea Compounds; Organoplatinum Compounds; Taxoids | 2017 |
Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Cisplatin; Disaccharides; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Drug Combinations; Drug Synergism; Female; Humans; Injections, Intravenous; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous; Xenograft Model Antitumor Assays | 2008 |